Superbug and viral pathogen treatment developer Recce Pharmacetical (ASX:RCE)’s unapproved drug R327 has successfully saved a patient suffering a life-threatening illness.
Despite not undertaking clinical trials, nasal treatment R327 was accessible to the individual via Category A of the Therapeutic Goods Administration special access scheme. Recce (ASX:RCE) intends to proceed with clinical trials for the product.
The news has shot Recce’s shares up 5.1 per cent to $1.03
Copyright 2021 – Finance News Network
06 Feb 2020 - Alliance Aviation Services (ASX:AQZ) announced a record first half profit before tax (PBT) result of $15.5 million for the half year ended 31 December 2019, an increase of $1.4 million or 10 per cent on the prior comparative period.
23 Dec 2019 - Vocus Group (ASX:VOC) has reached an agreement to settle the class action commenced against it in April 2019 in the Federal Court of Australia.
20 Sep 2019 - Aus Tin Mining (ASX:ANW) has announced a strategic review of the Granville operation. Meanwhile, DGR Global has reiterated its backing in a letter of funding support to the company for $1M over 12 months.
14 Feb 2020 - Regional Express (ASX:REX) report that New South Wales Ambulance and Pel-Air have entered into a contract to provide Fixed Wing Patient Transport Services to NSW Ambulance.
22 Feb 2024 - A snapshot of the stocks on the move, featuring 88 Energy (ASX:88E, AIM:88E, OTC:EEENF), Auric Mining (ASX:AWJ) and LBT Innovations (ASX:LBT).
25 May 2022 - Three iron ore companies that have hit 52-week highs. A deep dive on the backdrop and why this could be the case, featuring TerraCom (ASX:TER), Stanmore Resources (ASX:SMR), and Grange Resources (ASX:GRR).
30 Dec 2019 - Retirement village owner and operator, Metlifecare (ASX:MEQ) has penned a scheme of arrangement under which Asia Pacific Village Group will purchase all of its shares for $7.00 per share.
